[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Heparin Industry Research Report 2024

April 2024 | 124 pages | ID: H3319F53BCA0EN
APO Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

Heparin, a highly sulfated glycosaminoglycan, is widely used as an injectable anticoagulant, and has the highest negative charge density of any known biological molecule. It can also be used to form an inner anticoagulant surface on various experimental and medical devices such as test tubes and renal dialysis machine. Most of the Heparin product is existed in a form of Heparin Sodium or Heparin Calcium. This report is revolving around Heparin Active Pharmaceutical Ingredients (API).

According to APO Research, The global Heparin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Heparin is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Heparin include , etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Heparin.

The report will help the Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The Heparin market size, estimations, and forecasts are provided in terms of sales volume (B Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:
  • Hepalink
  • Changshan Pharm
  • Qianhong Bio-pharma
  • Opocrin
  • Pfizer
  • Aspen Oss
  • King-friend Biochemical Pharmaceutical
  • Bioibйrica
  • Dongcheng Biochemicals
  • Jiulong Biochemicals
  • Tiandong
  • Xinbai
  • Yino Pharma
  • Deebio
Heparin segment by Type
  • Heparin Sodium Raw Material Drug
  • Heparin Calcium Raw Material Drug
Heparin segment by Application
  • Low Molecular Weight Heparin Preparation
  • Standard Heparin Preparation
Heparin Segment by Region
  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
  • Asia-Pacific
    • China
    • Japan
    • South Korea
    • India
    • Australia
    • China Taiwan
    • Indonesia
    • Thailand
    • Malaysia
  • Latin America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • Turkey
    • Saudi Arabia
    • UAE
Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Heparin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Heparin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Heparin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Heparin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Heparin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Heparin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.
1 PREFACE

1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
  1.5.1 Secondary Sources
  1.5.2 Primary Sources

2 MARKET OVERVIEW

2.1 Product Definition
2.2 Heparin by Type
  2.2.1 Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
  2.2.2 Heparin Sodium Raw Material Drug
  2.2.3 Heparin Calcium Raw Material Drug
2.3 Heparin by Application
  2.3.1 Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
  2.3.2 Low Molecular Weight Heparin Preparation
  2.3.3 Standard Heparin Preparation
2.4 Global Market Growth Prospects
  2.4.1 Global Heparin Production Value Estimates and Forecasts (2019-2030)
  2.4.2 Global Heparin Production Capacity Estimates and Forecasts (2019-2030)
  2.4.3 Global Heparin Production Estimates and Forecasts (2019-2030)
  2.4.4 Global Heparin Market Average Price (2019-2030)

3 MARKET COMPETITIVE LANDSCAPE BY MANUFACTURERS

3.1 Global Heparin Production by Manufacturers (2019-2024)
3.2 Global Heparin Production Value by Manufacturers (2019-2024)
3.3 Global Heparin Average Price by Manufacturers (2019-2024)
3.4 Global Heparin Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
3.5 Global Heparin Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global Heparin Manufacturers, Product Type & Application
3.7 Global Heparin Manufacturers, Date of Enter into This Industry
3.8 Global Heparin Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition

4 MANUFACTURERS PROFILED

4.1 Hepalink
  4.1.1 Hepalink Heparin Company Information
  4.1.2 Hepalink Heparin Business Overview
  4.1.3 Hepalink Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.1.4 Hepalink Product Portfolio
  4.1.5 Hepalink Recent Developments
4.2 Changshan Pharm
  4.2.1 Changshan Pharm Heparin Company Information
  4.2.2 Changshan Pharm Heparin Business Overview
  4.2.3 Changshan Pharm Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.2.4 Changshan Pharm Product Portfolio
  4.2.5 Changshan Pharm Recent Developments
4.3 Qianhong Bio-pharma
  4.3.1 Qianhong Bio-pharma Heparin Company Information
  4.3.2 Qianhong Bio-pharma Heparin Business Overview
  4.3.3 Qianhong Bio-pharma Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.3.4 Qianhong Bio-pharma Product Portfolio
  4.3.5 Qianhong Bio-pharma Recent Developments
4.4 Opocrin
  4.4.1 Opocrin Heparin Company Information
  4.4.2 Opocrin Heparin Business Overview
  4.4.3 Opocrin Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.4.4 Opocrin Product Portfolio
  4.4.5 Opocrin Recent Developments
4.5 Pfizer
  4.5.1 Pfizer Heparin Company Information
  4.5.2 Pfizer Heparin Business Overview
  4.5.3 Pfizer Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.5.4 Pfizer Product Portfolio
  4.5.5 Pfizer Recent Developments
4.6 Aspen Oss
  4.6.1 Aspen Oss Heparin Company Information
  4.6.2 Aspen Oss Heparin Business Overview
  4.6.3 Aspen Oss Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.6.4 Aspen Oss Product Portfolio
  4.6.5 Aspen Oss Recent Developments
4.7 King-friend Biochemical Pharmaceutical
  4.7.1 King-friend Biochemical Pharmaceutical Heparin Company Information
  4.7.2 King-friend Biochemical Pharmaceutical Heparin Business Overview
  4.7.3 King-friend Biochemical Pharmaceutical Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.7.4 King-friend Biochemical Pharmaceutical Product Portfolio
  4.7.5 King-friend Biochemical Pharmaceutical Recent Developments
4.8 Bioibйrica
  4.8.1 Bioibйrica Heparin Company Information
  4.8.2 Bioibйrica Heparin Business Overview
  4.8.3 Bioibйrica Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.8.4 Bioibйrica Product Portfolio
  4.8.5 Bioibйrica Recent Developments
4.9 Dongcheng Biochemicals
  4.9.1 Dongcheng Biochemicals Heparin Company Information
  4.9.2 Dongcheng Biochemicals Heparin Business Overview
  4.9.3 Dongcheng Biochemicals Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.9.4 Dongcheng Biochemicals Product Portfolio
  4.9.5 Dongcheng Biochemicals Recent Developments
4.10 Jiulong Biochemicals
  4.10.1 Jiulong Biochemicals Heparin Company Information
  4.10.2 Jiulong Biochemicals Heparin Business Overview
  4.10.3 Jiulong Biochemicals Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.10.4 Jiulong Biochemicals Product Portfolio
  4.10.5 Jiulong Biochemicals Recent Developments
4.11 Tiandong
  4.11.1 Tiandong Heparin Company Information
  4.11.2 Tiandong Heparin Business Overview
  4.11.3 Tiandong Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.11.4 Tiandong Product Portfolio
  4.11.5 Tiandong Recent Developments
4.12 Xinbai
  4.12.1 Xinbai Heparin Company Information
  4.12.2 Xinbai Heparin Business Overview
  4.12.3 Xinbai Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.12.4 Xinbai Product Portfolio
  4.12.5 Xinbai Recent Developments
4.13 Yino Pharma
  4.13.1 Yino Pharma Heparin Company Information
  4.13.2 Yino Pharma Heparin Business Overview
  4.13.3 Yino Pharma Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.13.4 Yino Pharma Product Portfolio
  4.13.5 Yino Pharma Recent Developments
4.14 Deebio
  4.14.1 Deebio Heparin Company Information
  4.14.2 Deebio Heparin Business Overview
  4.14.3 Deebio Heparin Production Capacity, Value and Gross Margin (2019-2024)
  4.14.4 Deebio Product Portfolio
  4.14.5 Deebio Recent Developments

5 GLOBAL HEPARIN PRODUCTION BY REGION

5.1 Global Heparin Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.2 Global Heparin Production by Region: 2019-2030
  5.2.1 Global Heparin Production by Region: 2019-2024
  5.2.2 Global Heparin Production Forecast by Region (2025-2030)
5.3 Global Heparin Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
5.4 Global Heparin Production Value by Region: 2019-2030
  5.4.1 Global Heparin Production Value by Region: 2019-2024
  5.4.2 Global Heparin Production Value Forecast by Region (2025-2030)
5.5 Global Heparin Market Price Analysis by Region (2019-2024)
5.6 Global Heparin Production and Value, YOY Growth
  5.6.1 North America Heparin Production Value Estimates and Forecasts (2019-2030)
  5.6.2 Europe Heparin Production Value Estimates and Forecasts (2019-2030)
  5.6.3 China Heparin Production Value Estimates and Forecasts (2019-2030)
  5.6.4 Mexico Heparin Production Value Estimates and Forecasts (2019-2030)

6 GLOBAL HEPARIN CONSUMPTION BY REGION

6.1 Global Heparin Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
6.2 Global Heparin Consumption by Region (2019-2030)
  6.2.1 Global Heparin Consumption by Region: 2019-2030
  6.2.2 Global Heparin Forecasted Consumption by Region (2025-2030)
6.3 North America
  6.3.1 North America Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  6.3.2 North America Heparin Consumption by Country (2019-2030)
  6.3.3 U.S.
  6.3.4 Canada
6.4 Europe
  6.4.1 Europe Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  6.4.2 Europe Heparin Consumption by Country (2019-2030)
  6.4.3 Germany
  6.4.4 France
  6.4.5 U.K.
  6.4.6 Italy
  6.4.7 Russia
6.5 Asia Pacific
  6.5.1 Asia Pacific Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  6.5.2 Asia Pacific Heparin Consumption by Country (2019-2030)
  6.5.3 China
  6.5.4 Japan
  6.5.5 South Korea
  6.5.6 China Taiwan
  6.5.7 Southeast Asia
  6.5.8 India
  6.5.9 Australia
6.6 Latin America, Middle East & Africa
  6.6.1 Latin America, Middle East & Africa Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
  6.6.2 Latin America, Middle East & Africa Heparin Consumption by Country (2019-2030)
  6.6.3 Mexico
  6.6.4 Brazil
  6.6.5 Turkey
  6.6.5 GCC Countries

7 SEGMENT BY TYPE

7.1 Global Heparin Production by Type (2019-2030)
  7.1.1 Global Heparin Production by Type (2019-2030) & (B Units)
  7.1.2 Global Heparin Production Market Share by Type (2019-2030)
7.2 Global Heparin Production Value by Type (2019-2030)
  7.2.1 Global Heparin Production Value by Type (2019-2030) & (US$ Million)
  7.2.2 Global Heparin Production Value Market Share by Type (2019-2030)
7.3 Global Heparin Price by Type (2019-2030)

8 SEGMENT BY APPLICATION

8.1 Global Heparin Production by Application (2019-2030)
  8.1.1 Global Heparin Production by Application (2019-2030) & (B Units)
  8.1.2 Global Heparin Production by Application (2019-2030) & (B Units)
8.2 Global Heparin Production Value by Application (2019-2030)
  8.2.1 Global Heparin Production Value by Application (2019-2030) & (US$ Million)
  8.2.2 Global Heparin Production Value Market Share by Application (2019-2030)
8.3 Global Heparin Price by Application (2019-2030)

9 VALUE CHAIN AND SALES CHANNELS ANALYSIS OF THE MARKET

9.1 Heparin Value Chain Analysis
  9.1.1 Heparin Key Raw Materials
  9.1.2 Raw Materials Key Suppliers
  9.1.3 Heparin Production Mode & Process
9.2 Heparin Sales Channels Analysis
  9.2.1 Direct Comparison with Distribution Share
  9.2.2 Heparin Distributors
  9.2.3 Heparin Customers

10 GLOBAL HEPARIN ANALYZING MARKET DYNAMICS

10.1 Heparin Industry Trends
10.2 Heparin Industry Drivers
10.3 Heparin Industry Opportunities and Challenges
10.4 Heparin Industry Restraints

11 REPORT CONCLUSION

12 DISCLAIMER


LIST OF TABLES

Table 1. Secondary Sources
Table 2. Primary Sources
Table 3. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Table 4. Market Value Comparison by Application (2019 VS 2023 VS 2030) & (US$ Million)
Table 5. Global Heparin Production by Manufacturers (B Units) & (2019-2024)
Table 6. Global Heparin Production Market Share by Manufacturers
Table 7. Global Heparin Production Value by Manufacturers (US$ Million) & (2019-2024)
Table 8. Global Heparin Production Value Market Share by Manufacturers (2019-2024)
Table 9. Global Heparin Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 10. Global Heparin Industry Manufacturers Ranking, 2022 VS 2023 VS 2024
Table 11. Global Heparin Manufacturers, Product Type & Application
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Heparin by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value of 2023)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans)
Table 15. Hepalink Heparin Company Information
Table 16. Hepalink Business Overview
Table 17. Hepalink Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 18. Hepalink Product Portfolio
Table 19. Hepalink Recent Developments
Table 20. Changshan Pharm Heparin Company Information
Table 21. Changshan Pharm Business Overview
Table 22. Changshan Pharm Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 23. Changshan Pharm Product Portfolio
Table 24. Changshan Pharm Recent Developments
Table 25. Qianhong Bio-pharma Heparin Company Information
Table 26. Qianhong Bio-pharma Business Overview
Table 27. Qianhong Bio-pharma Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 28. Qianhong Bio-pharma Product Portfolio
Table 29. Qianhong Bio-pharma Recent Developments
Table 30. Opocrin Heparin Company Information
Table 31. Opocrin Business Overview
Table 32. Opocrin Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 33. Opocrin Product Portfolio
Table 34. Opocrin Recent Developments
Table 35. Pfizer Heparin Company Information
Table 36. Pfizer Business Overview
Table 37. Pfizer Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 38. Pfizer Product Portfolio
Table 39. Pfizer Recent Developments
Table 40. Aspen Oss Heparin Company Information
Table 41. Aspen Oss Business Overview
Table 42. Aspen Oss Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 43. Aspen Oss Product Portfolio
Table 44. Aspen Oss Recent Developments
Table 45. King-friend Biochemical Pharmaceutical Heparin Company Information
Table 46. King-friend Biochemical Pharmaceutical Business Overview
Table 47. King-friend Biochemical Pharmaceutical Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 48. King-friend Biochemical Pharmaceutical Product Portfolio
Table 49. King-friend Biochemical Pharmaceutical Recent Developments
Table 50. Bioibйrica Heparin Company Information
Table 51. Bioibйrica Business Overview
Table 52. Bioibйrica Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 53. Bioibйrica Product Portfolio
Table 54. Bioibйrica Recent Developments
Table 55. Dongcheng Biochemicals Heparin Company Information
Table 56. Dongcheng Biochemicals Business Overview
Table 57. Dongcheng Biochemicals Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 58. Dongcheng Biochemicals Product Portfolio
Table 59. Dongcheng Biochemicals Recent Developments
Table 60. Jiulong Biochemicals Heparin Company Information
Table 61. Jiulong Biochemicals Business Overview
Table 62. Jiulong Biochemicals Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 63. Jiulong Biochemicals Product Portfolio
Table 64. Jiulong Biochemicals Recent Developments
Table 65. Tiandong Heparin Company Information
Table 66. Tiandong Business Overview
Table 67. Tiandong Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 68. Tiandong Product Portfolio
Table 69. Tiandong Recent Developments
Table 70. Xinbai Heparin Company Information
Table 71. Xinbai Business Overview
Table 72. Xinbai Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Xinbai Product Portfolio
Table 74. Xinbai Recent Developments
Table 75. Yino Pharma Heparin Company Information
Table 76. Yino Pharma Business Overview
Table 77. Yino Pharma Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. Yino Pharma Product Portfolio
Table 79. Yino Pharma Recent Developments
Table 80. Deebio Heparin Company Information
Table 81. Deebio Business Overview
Table 82. Deebio Heparin Production Capacity (B Units), Value (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Deebio Product Portfolio
Table 84. Deebio Recent Developments
Table 85. Global Heparin Production Comparison by Region: 2019 VS 2023 VS 2030 (B Units)
Table 86. Global Heparin Production by Region (2019-2024) & (B Units)
Table 87. Global Heparin Production Market Share by Region (2019-2024)
Table 88. Global Heparin Production Forecast by Region (2025-2030) & (B Units)
Table 89. Global Heparin Production Market Share Forecast by Region (2025-2030)
Table 90. Global Heparin Production Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 91. Global Heparin Production Value by Region (2019-2024) & (US$ Million)
Table 92. Global Heparin Production Value Market Share by Region (2019-2024)
Table 93. Global Heparin Production Value Forecast by Region (2025-2030) & (US$ Million)
Table 94. Global Heparin Production Value Market Share Forecast by Region (2025-2030)
Table 95. Global Heparin Market Average Price (USD/Unit) by Region (2019-2024)
Table 96. Global Heparin Consumption Comparison by Region: 2019 VS 2023 VS 2030 (B Units)
Table 97. Global Heparin Consumption by Region (2019-2024) & (B Units)
Table 98. Global Heparin Consumption Market Share by Region (2019-2024)
Table 99. Global Heparin Forecasted Consumption by Region (2025-2030) & (B Units)
Table 100. Global Heparin Forecasted Consumption Market Share by Region (2025-2030)
Table 101. North America Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (B Units)
Table 102. North America Heparin Consumption by Country (2019-2024) & (B Units)
Table 103. North America Heparin Consumption by Country (2025-2030) & (B Units)
Table 104. Europe Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (B Units)
Table 105. Europe Heparin Consumption by Country (2019-2024) & (B Units)
Table 106. Europe Heparin Consumption by Country (2025-2030) & (B Units)
Table 107. Asia Pacific Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (B Units)
Table 108. Asia Pacific Heparin Consumption by Country (2019-2024) & (B Units)
Table 109. Asia Pacific Heparin Consumption by Country (2025-2030) & (B Units)
Table 110. Latin America, Middle East & Africa Heparin Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (B Units)
Table 111. Latin America, Middle East & Africa Heparin Consumption by Country (2019-2024) & (B Units)
Table 112. Latin America, Middle East & Africa Heparin Consumption by Country (2025-2030) & (B Units)
Table 113. Global Heparin Production by Type (2019-2024) & (B Units)
Table 114. Global Heparin Production by Type (2025-2030) & (B Units)
Table 115. Global Heparin Production Market Share by Type (2019-2024)
Table 116. Global Heparin Production Market Share by Type (2025-2030)
Table 117. Global Heparin Production Value by Type (2019-2024) & (US$ Million)
Table 118. Global Heparin Production Value by Type (2025-2030) & (US$ Million)
Table 119. Global Heparin Production Value Market Share by Type (2019-2024)
Table 120. Global Heparin Production Value Market Share by Type (2025-2030)
Table 121. Global Heparin Price by Type (2019-2024) & (USD/Unit)
Table 122. Global Heparin Price by Type (2025-2030) & (USD/Unit)
Table 123. Global Heparin Production by Application (2019-2024) & (B Units)
Table 124. Global Heparin Production by Application (2025-2030) & (B Units)
Table 125. Global Heparin Production Market Share by Application (2019-2024)
Table 126. Global Heparin Production Market Share by Application (2025-2030)
Table 127. Global Heparin Production Value by Application (2019-2024) & (US$ Million)
Table 128. Global Heparin Production Value by Application (2025-2030) & (US$ Million)
Table 129. Global Heparin Production Value Market Share by Application (2019-2024)
Table 130. Global Heparin Production Value Market Share by Application (2025-2030)
Table 131. Global Heparin Price by Application (2019-2024) & (USD/Unit)
Table 132. Global Heparin Price by Application (2025-2030) & (USD/Unit)
Table 133. Key Raw Materials
Table 134. Raw Materials Key Suppliers
Table 135. Heparin Distributors List
Table 136. Heparin Customers List
Table 137. Heparin Industry Trends
Table 138. Heparin Industry Drivers
Table 139. Heparin Industry Restraints
Table 140. Authors List of This Report

LIST OF FIGURES

Figure 1. Research Methodology
Figure 2. Research Process
Figure 3. Key Executives Interviewed
Figure 4. HeparinProduct Picture
Figure 5. Market Value Comparison by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 6. Heparin Sodium Raw Material Drug Product Picture
Figure 7. Heparin Calcium Raw Material Drug Product Picture
Figure 8. Low Molecular Weight Heparin Preparation Product Picture
Figure 9. Standard Heparin Preparation Product Picture
Figure 10. Global Heparin Production Value (US$ Million), 2019 VS 2023 VS 2030
Figure 11. Global Heparin Production Value (2019-2030) & (US$ Million)
Figure 12. Global Heparin Production Capacity (2019-2030) & (B Units)
Figure 13. Global Heparin Production (2019-2030) & (B Units)
Figure 14. Global Heparin Average Price (USD/Unit) & (2019-2030)
Figure 15. Global Heparin Key Manufacturers, Manufacturing Sites & Headquarters
Figure 16. Global Heparin Manufacturers, Date of Enter into This Industry
Figure 17. Global Top 5 and 10 Heparin Players Market Share by Production Valu in 2023
Figure 18. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 19. Global Heparin Production Comparison by Region: 2019 VS 2023 VS 2030 (B Units)
Figure 20. Global Heparin Production Market Share by Region: 2019 VS 2023 VS 2030
Figure 21. Global Heparin Production Value Comparison by Region: 2019 VS 2023 VS 2030 (US$ Million)
Figure 22. Global Heparin Production Value Market Share by Region: 2019 VS 2023 VS 2030
Figure 23. North America Heparin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 24. Europe Heparin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 25. China Heparin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 26. Mexico Heparin Production Value (US$ Million) Growth Rate (2019-2030)
Figure 27. Global Heparin Consumption Comparison by Region: 2019 VS 2023 VS 2030 (B Units)
Figure 28. Global Heparin Consumption Market Share by Region: 2019 VS 2023 VS 2030
Figure 29. North America Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 30. North America Heparin Consumption Market Share by Country (2019-2030)
Figure 31. United States Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 32. Canada Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 33. Europe Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 34. Europe Heparin Consumption Market Share by Country (2019-2030)
Figure 35. Germany Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 36. France Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 37. U.K. Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 38. Italy Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 39. Netherlands Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 40. Asia Pacific Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 41. Asia Pacific Heparin Consumption Market Share by Country (2019-2030)
Figure 42. China Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 43. Japan Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 44. South Korea Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 45. China Taiwan Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 46. Southeast Asia Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 47. India Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 48. Australia Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 49. Latin America, Middle East & Africa Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 50. Latin America, Middle East & Africa Heparin Consumption Market Share by Country (2019-2030)
Figure 51. Mexico Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 52. Brazil Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 53. Turkey Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 54. GCC Countries Heparin Consumption and Growth Rate (2019-2030) & (B Units)
Figure 55. Global Heparin Production Market Share by Type (2019-2030)
Figure 56. Global Heparin Production Value Market Share by Type (2019-2030)
Figure 57. Global Heparin Price (USD/Unit) by Type (2019-2030)
Figure 58. Global Heparin Production Market Share by Application (2019-2030)
Figure 59. Global Heparin Production Value Market Share by Application (2019-2030)
Figure 60. Global Heparin Price (USD/Unit) by Application (2019-2030)
Figure 61. Heparin Value Chain
Figure 62. Heparin Production Mode & Process
Figure 63. Direct Comparison with Distribution Share
Figure 64. Distributors Profiles
Figure 65. Heparin Industry Opportunities and Challenges


More Publications